Answers are grounded in this paper and cite their sources.
We describe here a chemically controlled pathway for the designed synthesis of iron oxide nanoparticles by thermal decomposition of iron(II) and iron(III) oxalates in high-boiling solvents in the presence of oleylamine and oleic acid acting as capping ligands. The phase composition of the nanocrystals (Fe, FeO, Fe 3 O 4, or α-Fe 2 O 3 ) could be precisely controlled by adjusting the synthesis conditions or by addition of appropriate oxidants, such as trimethylamine- N -oxide (TMAO), which produced highly monodisperse iron(III) oxide particles in the range of 6–25 nm in good yields. The decomposition behavior of different precursor/TMAO mixtures was elucidated by differential scanning calorimetry and thermogravimetry, and resulting particles were characterized by comprehensive HR-TEM and XRD analyses.
No takes yet. Share an insight, caveat, or question.
Cavelius et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: